TY  - GEN
AU  - Paiva,J A
AU  - Mergulhão,P
AU  - Gomes,A
AU  - Taccone,F S
AU  - Van den Abeele,A-M
AU  - Bulpa,P
AU  - Misset,B
AU  - Meersseman,W
AU  - Dimopoulos,G
AU  - Rello,J
AU  - Vogelaers,D
AU  - Blot,S
TI  - Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures
SN  - 1872-7913
PY  - 2018///0613
KW  - Aged
KW  - Amphotericin B
KW  - therapeutic use
KW  - Antifungal Agents
KW  - Aspergillus
KW  - drug effects
KW  - Clinical Decision-Making
KW  - Critical Illness
KW  - Delayed Diagnosis
KW  - mortality
KW  - Drug Therapy, Combination
KW  - Echinocandins
KW  - Female
KW  - Fungal Proteins
KW  - Humans
KW  - Intensive Care Units
KW  - Invasive Pulmonary Aspergillosis
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Respiratory System
KW  - microbiology
KW  - Treatment Outcome
KW  - Voriconazole
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.ijantimicag.2017.05.017
ER  -